These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16269936)

  • 21. ADAMTS-13 activity in plasma is rapidly measured by a new ELISA method that uses recombinant VWF-A2 domain as substrate.
    Whitelock JL; Nolasco L; Bernardo A; Moake J; Dong JF; Cruz MA
    J Thromb Haemost; 2004 Mar; 2(3):485-91. PubMed ID: 15009467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in von Willebrand factor-cleaving protease (ADAMTS-13) in patients with aortic stenosis undergoing valve replacement or balloon valvuloplasty.
    Bander J; Elmariah S; Aledort LM; Dlott J; Stelzer P; Halperin JL; Kini AS; Sharma SK
    Thromb Haemost; 2012 Jul; 108(1):86-93. PubMed ID: 22627470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding.
    Bartoli CR; Kang J; Restle DJ; Zhang DM; Shabahang C; Acker MA; Atluri P
    JACC Heart Fail; 2015 Nov; 3(11):860-9. PubMed ID: 26454844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Genetic polymorphism of von Willebrand factor (VWF)-cleaving protease, ADAMTS13].
    Kokame K
    Brain Nerve; 2008 Nov; 60(11):1325-32. PubMed ID: 19069166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of von Willebrand factor-cleaving protease (ADAMTS-13) in human platelets.
    Suzuki M; Murata M; Matsubara Y; Uchida T; Ishihara H; Shibano T; Ashida S; Soejima K; Okada Y; Ikeda Y
    Biochem Biophys Res Commun; 2004 Jan; 313(1):212-6. PubMed ID: 14672719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ADAMTS13 regulation of VWF multimer distribution in severe COVID-19.
    Ward SE; Fogarty H; Karampini E; Lavin M; Schneppenheim S; Dittmer R; Morrin H; Glavey S; Ni Cheallaigh C; Bergin C; Martin-Loeches I; Mallon PW; Curley GF; Baker RI; Budde U; O'Sullivan JM; O'Donnell JS;
    J Thromb Haemost; 2021 Aug; 19(8):1914-1921. PubMed ID: 34053187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of ADAMT-13 in platelet adhesion in flow: methods for diagnosis of thrombotic thrombocytopenic purpura.
    Shenkman B
    Pathophysiol Haemost Thromb; 2006; 35(1-2):98-102. PubMed ID: 16855353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13: A new prothrombotic mechanism in diseases associated with oxidative stress.
    Lancellotti S; De Filippis V; Pozzi N; Peyvandi F; Palla R; Rocca B; Rutella S; Pitocco D; Mannucci PM; De Cristofaro R
    Free Radic Biol Med; 2010 Feb; 48(3):446-56. PubMed ID: 19969076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial cell ADAMTS-13 and VWF: production, release, and VWF string cleavage.
    Turner NA; Nolasco L; Ruggeri ZM; Moake JL
    Blood; 2009 Dec; 114(24):5102-11. PubMed ID: 19822897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome.
    Lattuada A; Rossi E; Calzarossa C; Candolfi R; Mannucci PM
    Haematologica; 2003 Sep; 88(9):1029-34. PubMed ID: 12969811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of von Willebrand factor and ADAMTS-13 antigen and activity levels in sickle cell disease patients in Kuwait.
    Al-Awadhi A; Adekile A; Marouf R
    J Thromb Thrombolysis; 2017 Jan; 43(1):117-123. PubMed ID: 27613177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shear-Induced Unfolding and Enzymatic Cleavage of Full-Length VWF Multimers.
    Lippok S; Radtke M; Obser T; Kleemeier L; Schneppenheim R; Budde U; Netz RR; Rädler JO
    Biophys J; 2016 Feb; 110(3):545-554. PubMed ID: 26840720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further characterization of ADAMTS-13 inactivation by thrombin.
    Lam JK; Chion CK; Zanardelli S; Lane DA; Crawley JT
    J Thromb Haemost; 2007 May; 5(5):1010-8. PubMed ID: 17355572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered von Willebrand factor subunit proteolysis and multimer processing associated with the Cys2362Phe mutation in the B2 domain.
    Casonato A; De Marco L; Gallinaro L; Sztukowska M; Mazzuccato M; Battiston M; Pagnan A; Ruggeri ZM
    Thromb Haemost; 2007 Apr; 97(4):527-33. PubMed ID: 17393013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smoking, von Willebrand factor and ADAMTS-13 in healthy males.
    Al-Awadhi AM; Jadaon MM; Alsayegh FA; Al-Sharrah SK
    Scand J Clin Lab Invest; 2012 Dec; 72(8):614-8. PubMed ID: 23020229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Von Willebrand factor cleaving protease activity in the physiopathology of microangiopathic disorders.
    Amaral MM; Kempfer AC; Farías CE; Carballo GA; Silaf MR; Lazzari MA
    Medicina (B Aires); 2003; 63(2):130-6. PubMed ID: 12793081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The WXXW motif in the TSR1 of ADAMTS13 is important for its secretion and proteolytic activity.
    Ling J; Su J; Ma Z; Ruan C
    Thromb Res; 2013 Jun; 131(6):529-34. PubMed ID: 23683325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival of von Willebrand factor released following DDAVP in a type 1 von Willebrand disease cohort: influence of glycosylation, proteolysis and gene mutations.
    Millar CM; Riddell AF; Brown SA; Starke R; Mackie I; Bowen DJ; Jenkins PV; van Mourik JA
    Thromb Haemost; 2008 May; 99(5):916-24. PubMed ID: 18449422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-free shear flow assay facilitates analysis of shear-dependent functions of VWF and ADAMTS13.
    Kraus E; Kraus K; Obser T; Oyen F; Klemm U; Schneppenheim R; Brehm MA
    Thromb Res; 2014 Dec; 134(6):1285-91. PubMed ID: 25201004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidation of Met1606 in von Willebrand factor is a risk factor for thrombotic and septic complications in chronic renal failure.
    De Filippis V; Lancellotti S; Maset F; Spolaore B; Pozzi N; Gambaro G; Oggianu L; Calò LA; De Cristofaro R
    Biochem J; 2012 Mar; 442(2):423-32. PubMed ID: 22091998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.